Anthem paying $594M to settle antitrust litigation, but deal terms might fuel growth
Some investment analysts and health care observers say changes to Blue Cross Blue Shield rules that are stipulated in a half-billion-dollar settlement are so favorable to Indianapolis-based Anthem’s growth prospects that they view the deal as a huge win for the company.